Zion Oil & Gas, Inc. (ZN) Failed to Disclose it Was the Subject of an SEC Investigation According to the filed class action complaint against the company’s officers and directors

Trevena, Inc. (TRVN) Accused of Lying to Investors About Critical FDA Meeting for Over Two Years According to a filed class action complaint against the company’s officers and directors for alleged

Applied Optoelectronics, Inc. (AAOI) Product Quality Issues Affect its Financials According to a filed complaint against the company’s officers and directors for violations of the Securities Exchange Act of 1934, on

Robbins LLP Is Investigating the Officers and Directors of Akorn, Inc. (AKRX) on Behalf of Shareholders Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of

TG Therapeutics, Inc. (TGTX) Accused of Misleading Investors Regarding Trial Results The actions concerns TG’s UNITY-CLL Trial. The trial is a randomized controlled Phase 3 trial under Special Protocol Assessment

Alnylam Pharmaceuticals, Inc. (ALNY) Overstated the Efficacy of its Onpattro Lipid Complex Injection According to the complaint, the U.S. Food and Drug Administration (“FDA”) approved patisiran for the treatment of

Impinj, Inc. (PI) Accused of Misleading Investors Regarding Product Demand According to the complaint, Impinj, Inc. (PI) told investors that the company was increasing inventory levels to meet rising market